Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Stock Information for Codexis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Codexis Inc.

Codexis to Report Second Quarter 2024 Financial Results on August 8
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
Codexis to Participate in Jefferies Global Healthcare Conference
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
Codexis Reports First Quarter 2024 Financial Results
Codexis to Report First Quarter 2024 Financial Results on May 2
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.